G. Rebecq, La prescription médicale. Presses universitaires Aix-Marseille, pp.63-79, 1998.

M. Andro, S. Estivin, and A. Gentric, Prescriptions m??dicamenteuses en g??riatrie??: overuse (sur-utilisation), misuse (mauvaise utilisation), underuse (sous-utilisation). Analyse qualitative ?? partir des ordonnances de 200??patients entrant dans un service de court s??jour g??riatrique, La Revue de M??decine Interne, vol.33, issue.3, pp.122-129, 2012.
DOI : 10.1016/j.revmed.2011.11.016

A. Spinewine, K. Schmader, N. Barber, C. Hughes, K. Lapane et al., Appropriate prescribing in elderly people: how well can it be measured and optimised?, The Lancet, vol.370, issue.9582, pp.173-84, 2007.
DOI : 10.1016/S0140-6736(07)61091-5

O. Mahony, D. Gallagher, and P. , Inappropriate prescribing in the older population: need for new criteria, Age and Ageing, vol.37, issue.2, pp.138-179, 2008.
DOI : 10.1093/ageing/afm189

P. Lang, Y. Hasso, J. Belmin, I. Payot, J. Baeyens et al., STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people], Can J Public Health, vol.100, issue.6, pp.426-457, 2009.

P. Rochon and J. Gurwitz, Drug therapy. Lancet, Jul, vol.1346, issue.8966, pp.32-38, 1995.

R. Maher, J. Hanlon, and E. Hajjar, Clinical consequences of polypharmacy in elderly, Expert Opinion on Drug Safety, vol.5, issue.1, pp.57-65
DOI : 10.2165/00003495-200969040-00001

M. Vélez-díaz-pallarés and A. Cruz-jentoft, A new version of the STOPP-START criteria, a new step towards improving drug prescription in older patients. European Geriatric Medicine, pp.363-367, 2014.

M. Beers, Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Archives of Internal Medicine, pp.1825-1857, 1991.

P. Mcleod, A. Huang, R. Tamblyn, and D. Gayton, Defining inappropriate practices in prescribing for elderly people: a national consensus panel, CMAJ. Feb, vol.1156, issue.3, pp.385-91, 1997.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, O. Mahony et al., Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment)

P. Shekelle, C. Maclean, S. Morton, and N. Wenger, Assessing Care of Vulnerable Elders: Methods for Developing Quality Indicators, Annals of Internal Medicine, vol.135, issue.8_Part_2, pp.647-52, 2001.
DOI : 10.7326/0003-4819-135-8_Part_2-200110161-00003

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, European Journal of Clinical Pharmacology, vol.23, issue.8, pp.725-756, 2007.
DOI : 10.1007/s00228-007-0324-2

F. García-gollarte, J. Baleriola-júlvez, I. Ferrero-lópez, and A. Cruz-jentoft, Inappropriate Drug Prescription at Nursing Home Admission, Journal of the American Medical Directors Association, vol.13, issue.1, pp.83-92
DOI : 10.1016/j.jamda.2011.02.009

I. Zuckerman, J. Hernandez, A. Gruber-baldini, J. Hebel, B. Stuart et al., Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia, The American Journal of Geriatric Pharmacotherapy, vol.3, issue.4, pp.246-54, 2005.
DOI : 10.1016/j.amjopharm.2005.12.007

C. Cool, P. Cestac, C. Laborde, C. Lebaudy, L. Rouch et al., Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes, Journal of the American Medical Directors Association, vol.15, issue.11, pp.850-851, 2014.
DOI : 10.1016/j.jamda.2014.08.003

C. Ruggiero, G. Dell-'aquila, B. Gasperini, G. Onder, F. Lattanzio et al., Potentially Inappropriate Drug Prescriptions and Risk of Hospitalization among Older, Italian, Nursing Home Residents, Drugs & Aging, vol.286, issue.4, pp.747-58, 2010.
DOI : 10.2165/11538240-000000000-00000

N. Lechevallier-michel, M. Gautier-bertrand, A. Alpérovitch, C. Berr, J. Belmin et al., Frequency and risk factors of potentially inappropriate medication use in a communitydwelling elderly population: results from the 3C Study, Eur J Clin Pharmacol, 2005.

A. San-josé, A. Agustí, X. Vidal, F. Formiga, A. López-soto et al., Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing, European Journal of Internal Medicine, vol.25, issue.8, pp.710-716, 2014.
DOI : 10.1016/j.ejim.2014.07.011

G. Onder, R. Liperoti, D. Fialova, E. Topinkova, M. Tosato et al., Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.67, issue.6, 2012.
DOI : 10.1093/gerona/glr233

D. Barreto, P. Lapeyre-mestre, M. Mathieu, C. Piau, C. Bouget et al., Prevalence and Associations of the Use of Proton-Pump Inhibitors in Nursing Homes: A Cross-Sectional Study, Journal of the American Medical Directors Association, 2013.

H. Hamzat, H. Sun, J. Ford, J. Macleod, R. Soiza et al., Inappropriate Prescribing of Proton Pump Inhibitors in Older Patients, Drugs & Aging, vol.33, issue.12, pp.681-90, 2012.
DOI : 10.1007/BF03262283

L. Pasina, A. Nobili, M. Tettamanti, F. Salerno, S. Corrao et al., Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly, European Journal of Internal Medicine, vol.22, issue.2, pp.205-215, 2011.
DOI : 10.1016/j.ejim.2010.11.009

J. Claudene, B. George, J. S. Korc, and . Ross, Appropriate proton pump inhibitor use among older adults: A retrospective chart review, The American Journal of Geriatric Pharmacotherapy, vol.6, issue.5, pp.249-254, 2008.

I. Services, Top 20 Global Therapeutic Classes Total Audited Markets. [internet]. [accès le 27, Disponible sur, 2010.

I. Services, Top 15 Global ProductsTotal Audited Markets. [internet]. [accès le 28, Disponible sur, 2009.

. Argumentaire and . Paris, Disponible sur : http://www.has-sante, 2009.

. Medscape, Dépense de santé 2013 : Lucentis, Humira, Crestor en tête des remboursements. [internet]. [accès le 28, Disponible sur, p.3600572

A. and A. Nationale-de-sécurité-du-médicament, Analyse des ventes de médicaments en France en 2013, 2014.

. Disponible-sur, HAS ? Haute Autorité de Santé Médicaments inhibiteurs de la pompe à protons chez l'adulte : réévaluation. Paris [internet]. [accès le 10 Disponible sur : http://www.has-sante.fr/portail NICE -National Institute for Clinical Excellence. Dyspepsia and gastro?oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro?oesophageal reflux disease, or both. Clinical guideline (update, 27_14-15-18_458.pdf 31 Disponible sur, 2009.

G. Sachs, J. Shin, and C. Howden, Review article: the clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology and Therapeutics, pp.2-8, 2006.

E. Yu, S. Bauer, P. Bain, and D. Bauer, Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies, The American Journal of Medicine, vol.124, issue.6, pp.519-545, 2011.
DOI : 10.1016/j.amjmed.2011.01.007

Y. Yang, J. Lewis, S. Epstein, and D. Metz, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-53, 2006.
DOI : 10.1001/jama.296.24.2947

M. Morgan, M. Barr, G. Mercogliano, and C. Kuntz, S1225 Proton Pump Inhibitors Increase Risk of Severe Disease Among Patients Hospitalized With Clostridium difficile Associated Diarrhea, Gastroenterology, vol.138, issue.5, p.208, 2010.
DOI : 10.1016/S0016-5085(10)60941-9

M. Howell, V. Novack, P. Grgurich, D. Soulliard, L. Novack et al., Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection, Archives of Internal Medicine, vol.170, issue.9, pp.784-90, 2010.
DOI : 10.1001/archinternmed.2010.89

W. Cheungpasitporn, C. Thongprayoon, W. Kittanamongkolchai, N. Srivali, P. Edmonds et al., Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies, Renal Failure, vol.29, issue.7, pp.1237-1278, 2015.
DOI : 10.1038/ki.2012.462

Y. Yang and D. Metz, Safety of Proton Pump Inhibitor Exposure, Gastroenterology, vol.139, issue.4, 2010.
DOI : 10.1053/j.gastro.2010.08.023

C. Stewart, B. Termanini, V. Sutliff, J. Serrano, F. Yu et al., Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy, Alimentary Pharmacology and Therapeutics, vol.183, issue.1, pp.83-98, 1998.
DOI : 10.1001/archinte.117.5.667

C. Giuliano, S. Wilhelm, and P. Kale-pradhan, Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis, Expert Review of Clinical Pharmacology, vol.5, issue.3, pp.337-381
DOI : 10.1586/ecp.12.20

R. Laheij, M. Sturkenboom, R. Hassing, J. Dieleman, B. Stricker et al., Risk of Community-Acquired Pneumonia and Use of Gastric Acid???Suppressive Drugs, JAMA, vol.292, issue.16, 2004.
DOI : 10.1001/jama.292.16.1955

M. Maggio, A. Corsonello, G. Ceda, C. Cattabiani, F. Lauretani et al., Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals, JAMA Internal Medicine, vol.173, issue.7, pp.518-541, 2013.
DOI : 10.1001/jamainternmed.2013.2851

M. Teramura-grönblad, J. Bell, M. Pöysti, T. Strandberg, J. Laurila et al., Risk of Death Associated With Use of PPIs in Three Cohorts of Institutionalized Older People in Finland, Journal of the American Medical Directors Association, vol.13, issue.5, pp.488-497
DOI : 10.1016/j.jamda.2012.03.003

D. Bhatt, B. Cryer, C. Contant, M. Cohen, A. Lanas et al., Clopidogrel with or without Omeprazole in Coronary Artery Disease, New England Journal of Medicine, vol.363, issue.20, pp.1909-1926, 2010.
DOI : 10.1056/NEJMoa1007964

C. Kwok, V. Jeevanantham, B. Dawn, and Y. Loke, No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Meta-analysis, International Journal of Cardiology, vol.167, issue.3, pp.965-74, 2013.
DOI : 10.1016/j.ijcard.2012.03.085

A. Nationale-de-sécurité-du-médicament, Bon usage des agents antiplaquettaires, Disponible sur, 2012.

F. Fda-drug-safety and . Communication, Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)

S. Canada, Inhibiteurs de la pompe à protons : risque de fractures osseuses -4 avril 2013. [internet]. [accès le 10, Disponible sur, 2015.

F. Food and D. Administration, Possible Increased Risk of Bone Fractures With Certain Antacid Drugs, Disponible sur : http://www.fda.gov/Drugs/DrugSafety, 2010.

S. Legrain and S. Lacaille, Prescription médicamenteuse du sujet âgé. EMC -Médecine, 2005.

A. Aha, expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, vol.52, issue.18, pp.1502-1519, 2008.

C. Mo, G. Sun, and Y. Wang, PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis, PLOS ONE, vol.16, issue.7, p.131558, 2015.
DOI : 10.1371/journal.pone.0131558.s003

P. Clerc, L. Breton, J. Mousques, and J. , ??tude Polychrome??: Une m??thode d'expertise pour optimiser des ordonnances de polyprescription en m??decine g??n??rale, Pratiques et Organisation des Soins, vol.40, issue.3, pp.167-175, 2009.
DOI : 10.3917/pos.403.0167

L. Sauvaget, R. L. Dabadie, S. Desblaches, J. Bernard, N. Vandenhende et al., Rapport sur l'utilisation des inhibiteurs de la pompe à protons : les recommandations françaises sont-elles respectées ? La Revue de Médecine Interne, pp.651-658, 2015.
DOI : 10.1016/j.revmed.2015.04.014

F. Ng, K. Lam, S. Wong, C. Chang, Y. Lau et al., Upper Gastrointestinal Bleeding in Patients with Aspirin and Clopidogrel Co-Therapy, Digestion, vol.77, issue.3-4, pp.3-4173, 2008.
DOI : 10.1159/000141264

M. Lettino, Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: Facts or fancies?, European Journal of Internal Medicine, vol.21, issue.6, pp.484-493, 2010.
DOI : 10.1016/j.ejim.2010.08.004

F. and D. Adminstration, Public-health advisory: Updated safety information about a drug interaction between clopidogrel bisulfate and omeprazole, www.fda.gov/Drugs, 2009.

E. Agency, Public statement on possible interaction between clopidogrel and proton pump inhibitors, pp.194-194, 2009.

. Lettre-aux-professionnels-de-santé and . Paris, Disponible sur : http://www.ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux- professionnels-de-sante/Interaction-entre-clopidogrel-et-les-inhibiteurs-de-la-pompe-a- protons-IPP-Lettre-aux-professionnels-de-sante, 2009.

C. Blochet, J. Vétel, and A. Vial, Etude d'usage des médicaments en EHPAD entre 2011 et 2013, Rev Geriatr, vol.40, issue.4, pp.209-233, 2015.

D. Barreto, P. Lapeyre-mestre, M. Mathieu, C. Piau, C. Bouget et al., A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study, The journal of nutrition, health & aging, vol.50, issue.4, pp.173-181, 2013.
DOI : 10.1007/s12603-013-0008-9

URL : https://hal.archives-ouvertes.fr/halshs-00847527

S. Guillaume, Analgesic consumption in nursing homes: observational study about 99 nursing homes, 1089.

M. Fulton and E. Allen, Polypharmacy in the elderly: A literature review, Journal of the American Academy of Nurse Practitioners, vol.66, issue.10, pp.123-155, 2005.
DOI : 10.1093/fampra/17.3.261

S. Bronskill, S. Gill, J. Paterson, C. Bell, G. Anderson et al., Exploring Variation in Rates of Polypharmacy Across Long Term Care Homes, Journal of the American Medical Directors Association, vol.13, issue.3, 2012.
DOI : 10.1016/j.jamda.2011.07.001

L. Dwyer, B. Han, D. Woodwell, and E. Rechtsteiner, Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey, The American Journal of Geriatric Pharmacotherapy, vol.8, issue.1, pp.63-72, 2010.
DOI : 10.1016/j.amjopharm.2010.01.001

H. Legrain and S. , Consommation Médicamenteuse chez le Sujet Agé. Consommation, Prescription, Iatrogénie et Observance, Disponible sur, 2005.

E. Hajjar, A. Cafiero, and J. Hanlon, Polypharmacy in elderly patients, The American Journal of Geriatric Pharmacotherapy, vol.5, issue.4, pp.345-51, 2007.
DOI : 10.1016/j.amjopharm.2007.12.002

J. Jyrkkä, H. Enlund, M. Korhonen, R. Sulkava, and S. Hartikainen, Polypharmacy Status as an Indicator of Mortality in an Elderly Population, Drugs & Aging, vol.57, issue.12, pp.1039-1087, 2009.
DOI : 10.2165/11319530-000000000-00000

Z. Marcum, M. Amuan, J. Hanlon, S. Aspinall, S. Handler et al., Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans, Journal of the American Geriatrics Society, vol.57, issue.1, pp.34-41
DOI : 10.1111/j.1532-5415.2011.03772.x

T. Field, J. Gurwitz, J. Avorn, D. Mccormick, S. Jain et al., Risk Factors for Adverse Drug Events Among Nursing Home Residents, Archives of Internal Medicine, vol.161, issue.13, pp.1629-1663, 2001.
DOI : 10.1001/archinte.161.13.1629

J. Damián, R. Pastor-barriuso, E. Valderrama-gama, and J. De-pedro-cuesta, Factors associated with falls among older adults living in institutions, BMC Geriatrics, vol.158, issue.1, p.6, 2013.
DOI : 10.1093/aje/kwg203

P. Verger, Ministère des affaires sociales et de la Santé. La politique du médicament en EHPAD, 2013.

Y. Beloosesky, O. Nenaydenko, G. Nevo, R. Adunsky, A. Weiss et al., Rates, variability, and associated factors of polypharmacy in nursing home patients, Clinical Interventions in Aging, vol.8, pp.1585-90, 2013.
DOI : 10.2147/CIA.S52698

M. Elseviers, V. Stichele, R. , V. Bortel, and L. , Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics, Pharmacoepidemiology and Drug Safety, vol.163, issue.22, pp.1041-1049, 2010.
DOI : 10.1002/pds.1983

E. Jano and R. Aparasu, Healthcare Outcomes Associated with Beers' Criteria: A Systematic Review, Annals of Pharmacotherapy, vol.41, issue.3, pp.438-485, 2007.
DOI : 10.1345/aph.1H473

D. Lau, J. Kasper, D. Potter, A. Lyles, and R. Bennett, Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents, Archives of Internal Medicine, vol.165, issue.1, pp.68-74, 2005.
DOI : 10.1001/archinte.165.1.68

M. Teramura-grönblad, H. Hosia-randell, S. Muurinen, and K. Pitkala, Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents. Scand J Prim Health Care, pp.154-163, 2010.

C. Glew and R. Rentler, Use of Proton Pump Inhibitors and Other Acid Suppressive Medications in Newly Admitted Nursing Facility Patients, Journal of the American Medical Directors Association, vol.8, issue.9, 2007.
DOI : 10.1016/j.jamda.2007.07.001

J. Tjia, M. Rothman, and D. Kiely, Daily Medication Use in Nursing Home Residents with Advanced Dementia, Journal of the American Geriatrics Society, vol.63, issue.5, pp.880-888, 2010.
DOI : 10.1111/j.1532-5415.2010.02819.x

P. Rane, S. Guha, S. Chatterjee, and R. Aparasu, 497 Prevalence and Predictors of Non-Evidence Based Proton Pump Inhibitor Use Among Elderly Nursing Home Residents in the USA, Gastroenterology, vol.148, issue.4, p.95
DOI : 10.1016/S0016-5085(15)30329-2

J. Bell, T. Strandberg, and M. Teramura-gronblad, Use of proton pump inhibitors and mortality among institutionalized older people, Arch Intern Med, vol.170, issue.17, pp.1604-1609, 2010.

A. Barrison, L. Jarboe, B. Weinberg, K. Nimmagadda, L. Sullivan et al., Patterns of proton pump inhibitor use in clinical practice, The American Journal of Medicine, vol.111, issue.6, pp.469-73, 2001.
DOI : 10.1016/S0002-9343(01)00901-9

S. Chiverton, C. Howden, D. Burget, and R. Hunt, Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration, Alimentary Pharmacology & Therapeutics, vol.98, issue.Suppl. 146, pp.103-114, 1992.
DOI : 10.1111/j.1365-2036.1992.tb00550.x

P. Peghini, P. Katz, N. Bracy, and D. Castell, Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors, The American Journal of Gastroenterology, vol.89, issue.108, pp.763-770, 1998.
DOI : 10.1046/j.1365-2036.1996.33175000.x

D. Johnson, W. Orr, J. Crawley, B. Traxler, J. Mccullough et al., Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial, The American Journal of Gastroenterology, vol.62, issue.9, pp.1914-1936, 2005.
DOI : 10.1046/j.1524-4733.2002.52101.x

C. Ryan, O. Mahony, D. Kennedy, J. Weedle, P. Cottrell et al., Potentially inappropriate prescribing in older residents in Irish nursing homes, Age and Ageing, vol.42, issue.1, 2013.
DOI : 10.1093/ageing/afs068

P. Nishtala and L. Soo, Proton pump inhibitors utilisation in older people in New Zealand from, Intern Med J. 2015, vol.45, issue.6, pp.624-633, 2005.

. Rome, Italy: Pensiero Scientifico Editore, 2006.

S. Rotman and T. Bishop, Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002???2009, PLoS ONE, vol.81, issue.1, p.56060, 2002.
DOI : 10.1371/journal.pone.0056060.t004

A. Lassen, J. Hallas, S. De-muckadell, and O. , Use of anti-secretory medication: a population-based cohort study, Alimentary Pharmacology and Therapeutics, vol.120, issue.5, pp.577-83, 2004.
DOI : 10.1046/j.1365-2036.1999.00524.x

S. Hollingworth, E. Duncan, and J. Martin, Marked increase in proton pump inhibitors use in Australia, Pharmacoepidemiology and Drug Safety, vol.28, issue.4, pp.1019-1043, 2010.
DOI : 10.1002/pds.1969

A. Raghunath, C. O-'morain, and R. Mcloughlin, Review article: the long-term use of proton-pump inhibitors, Alimentary Pharmacology and Therapeutics, vol.159, issue.5, pp.55-63, 2005.
DOI : 10.1080/003655201750422585

C. Cahir, T. Fahey, and L. Tilson, Proton pump inhibitors: potential cost reductions by applying prescribing guidelines, BMC Health Services Research, vol.11, issue.3, p.408, 2012.
DOI : 10.1586/erp.11.24

S. Ryder, O. Reilly, S. Miller, R. Ross, J. Jacyna et al., Long term acid suppressing treatment in general practice, BMJ, vol.308, issue.6932, pp.827-857, 1994.
DOI : 10.1136/bmj.308.6932.827

P. Lang and . Stopp-start, du nouveau dans la détection des prescriptions médicamenteuses inappropriées dans la population âgée, Rev Geriatr, vol.35, issue.5, pp.341-348, 2010.

F. Akram, Y. Huang, and V. Lim, Proton pump inhibitors: Are we still prescribing them without valid indications? Australas Med J, pp.465-70, 2014.

A. Jarchow-macdonald and A. Mangoni, Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board, Geriatrics & Gerontology International, vol.29, issue.13-14, pp.1002-1011, 2013.
DOI : 10.1111/ggi.12047

C. George, B. Korc, and J. Ross, Appropriate proton pump inhibitor use among older adults: A retrospective chart review. The American Journal of Geriatric Pharmacotherapy, 2008.

C. Baigent, L. Blackwell, and R. Collins, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, vol.373, pp.1849-1860, 2009.

C. Patrono, G. Rodriguez, L. Landolfi, R. Baigent, and C. , Low-Dose Aspirin for the Prevention of Atherothrombosis, New England Journal of Medicine, vol.353, issue.22, pp.2373-83, 2005.
DOI : 10.1056/NEJMra052717

M. Alberts, J. Eikelboom, and G. Hankey, Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation. The Lancet Neurology, pp.1066-81, 2012.

J. Weil, C. , D. Langman, and M. , Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, vol.310, issue.6983, pp.827-857, 1995.
DOI : 10.1136/bmj.310.6983.827

G. Cadiou, M. Adam, and C. , Antiplatelet drugs in the elderly : prescriptions often inappropriate and reduced tolerance by associated diseases and drugs. Fund Clin Pharmacol, pp.307-320, 2012.

P. Lang, Y. Hasso, and M. Dramé, Potentially inappropriate prescribing including underuse amongst older patients with cognitive or psychiatric co-morbidities, Age Ageing, 2010.

É. Gentes, M. Hertzog, T. Vogel, and P. Lang, Potentially inappropriate prescribing cardiovascular medications in the aged population: prospective study in a district hospital centre (France) Presse Med, Feb, vol.44, issue.2, pp.41-50, 2015.

O. Dalleur, A. Spinewine, and S. Henrard, Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging, pp.829-866, 2012.

A. Lanas, L. García-rodríguez, M. Arroyo, F. Gomollón, F. Feu et al., Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations, Gut, vol.55, issue.12, pp.1731-1739, 2006.
DOI : 10.1136/gut.2005.080754

Á. Lanas, P. Carrera-lasfuentes, Y. Arguedas, S. García, L. Bujanda et al., Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants, Clinical Gastroenterology and Hepatology, vol.13, issue.5, 2015.
DOI : 10.1016/j.cgh.2014.11.007

T. Coxib, . Trialists-'(-cnt-)-collaboration, N. Bhala, J. Emberson, and A. Merhi, Vascular and upper gastrointestinal effects of non-steriodal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials, Lancet, vol.382, pp.769-79, 2013.

S. Derry, R. Moore, and R. Rabbie, Topical NSAIDs for chronic musculoskeletal pain in adults, Cochrane Database Syst Rev, vol.9, p.7400, 2012.

R. Moore, Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs, BMJ, vol.316, issue.7128, pp.333-371, 1998.
DOI : 10.1136/bmj.316.7128.333

L. Sailler, G. Pugnet, and P. Arlet, Corticothérapie systémique : les mesures d'accompagnement. La Revue de Médecine Interne, pp.279-83, 2013.

. Prescrire, Intéractions médicamenteuses. Le guide 2015, 2015.

H. Conn and T. Poynard, Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy, Journal of Internal Medicine, vol.20, issue.Suppl. 6, pp.619-651, 1994.
DOI : 10.1111/j.1365-2796.1994.tb00855.x

J. Piper, W. Ray, and J. Daugherty, Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs, Annals of Internal Medicine, vol.114, issue.9, pp.735-775, 1991.
DOI : 10.7326/0003-4819-114-9-735

J. Dent, H. Serag, M. Wallander, and S. Johansson, Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, vol.54, issue.5, pp.710-717, 2005.
DOI : 10.1136/gut.2004.051821

A. Ruigomez, G. Rodriguez, L. Wallander, M. Johansson, S. Graffner et al., Natural history of gastro-oesophageal reflux disease diagnosed in general practice, Alimentary Pharmacology and Therapeutics, vol.18, issue.1, pp.751-760, 2004.
DOI : 10.1001/jama.287.15.1972

J. Mold, L. Reed, A. Davis, M. Allen, D. Decktor et al., Prevalence of gastroesophageal reflux in elderly patients in a primary care setting, Am J Gastroenterol, vol.86, issue.8, pp.965-70, 1991.

A. Soumekh, F. Schnoll-sussman, and P. Katz, Reflux and Acid Peptic Diseases in the Elderly, Clinics in Geriatric Medicine, vol.30, issue.1, pp.29-41, 2014.
DOI : 10.1016/j.cger.2013.10.006

G. Hurenkamp, H. Grundmeyer, P. Bindels, G. Tytgat, and R. Van-der-hulst, How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices, J Fam Pract, vol.51, issue.3, pp.241-246, 2002.

A. Hungin, G. Rubin, O. Flanagan, and H. , Long-term prescribing of proton pump inhibitors in general practice, Br J Gen Pract, vol.49, issue.443, pp.451-454, 1999.

A. Pilotto, M. Franceschi, G. Leandro, C. Scarcelli, D. Ambrosio et al., Clinical Features of Reflux Esophagitis in Older People: A Study of 840 Consecutive Patients, Journal of the American Geriatrics Society, vol.40, issue.(S, pp.1537-1579, 2006.
DOI : 10.1111/j.1532-5415.2006.00899.x

S. Roman and P. Kahrilas, The diagnosis and management of hiatus hernia, BMJ, vol.349, issue.oct23 1, p.6154, 2014.
DOI : 10.1136/bmj.g6154

S. Menon and N. Trudgill, Risk factors in the aetiology of hiatus hernia, European Journal of Gastroenterology & Hepatology, vol.23, issue.2, pp.133-141, 2011.
DOI : 10.1097/MEG.0b013e3283426f57

R. Gonthier, P. Blanc, and F. Stierlam, Faut-il traiter toutes les maladies de la personne ??g??e ?, Th??rapie, vol.59, issue.2, pp.227-259, 2004.
DOI : 10.2515/therapie:2004044

D. Ahrens, G. Behrens, W. Himmel, M. Kochen, and J. Chenot, Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care, International Journal of Clinical Practice, vol.16, issue.Suppl 3, pp.767-73, 2012.
DOI : 10.1111/j.1742-1241.2012.02973.x

M. Saad, A. Collins, N. Lobo, M. , O. Connor et al., Proton pump inhibitors: a survey of prescribing in an Irish general hospital, International Journal of Clinical Practice, vol.51, issue.1, pp.31-35, 2005.
DOI : 10.1111/j.1742-1241.2004.00298.x

D. Zink, M. Pohlman, M. Barnes, and M. Cannon, Long-term use of acid suppression started inappropriately during hospitalization, Alimentary Pharmacology and Therapeutics, vol.61, issue.10, pp.1203-1212, 2005.
DOI : 10.1001/jama.292.16.1955

K. Grant, N. Al-adhami, J. Tordoff, J. Livesey, G. Barbezat et al., Continuation of Proton Pump Inhibitors from Hospital to Community, Pharmacy World & Science, vol.172, issue.1, pp.189-93, 2006.
DOI : 10.1007/s11096-006-9028-4

F. Leri, M. Ayzenberg, S. Voyce, A. Klein, L. Hartz et al., Four-Year Trends of Inappropriate Proton Pump Inhibitor Use After Hospital Discharge, Southern Medical Journal, vol.106, issue.4, 2013.
DOI : 10.1097/SMJ.0b013e31828db01f

D. Imbaud, A. Morin, S. Picard, and F. Toujas, Evaluation de la politique française des médicaments génériques, 2012.

D. Ahrens, J. Chenot, G. Behrens, T. Grimmsmann, and M. Kochen, Appropriateness of treatment recommendations for PPI in hospital discharge letters, European Journal of Clinical Pharmacology, vol.10, issue.Suppl 2, 2010.
DOI : 10.1007/s00228-010-0871-9

URL : https://hal.archives-ouvertes.fr/hal-00613749

E. Reeve, J. Andrews, M. Wiese, I. Hendrix, M. Roberts et al., Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors, Annals of Pharmacotherapy, vol.13, issue.1, pp.29-38
DOI : 10.1371/journal.pone.0043617

S. Kripalani, F. Lefevre, C. Phillips, M. Williams, P. Basaviah et al., Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians, JAMA, vol.297, issue.8, pp.831-872, 2007.
DOI : 10.1001/jama.297.8.831

J. Podvin-deleplanque, C. Charani, and I. Verheyde, Un nouvel outil pour lutter contre la iatrogénie chez les personnes âgées, Rev Geriatr, vol.39, issue.10, pp.649-57, 2014.

. Pubmed, Dossier médical partagé : le retour annoncé de l'usine à gaz. [internet]. [accès le 02, Disponible sur, 2015.

?. Haute-autorité-de-santé and . Has, Synthèse médicale Volet de Synthèse Médicale (VSM) élaboré à partir du modèle métier de synthèse médicale. Paris. Octobre 2013. (en ligne). (accès le 08, 2015.

K. Khunti and B. Kinsella, Short report. Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents, Age and Ageing, vol.29, issue.5, pp.451-454, 2000.
DOI : 10.1093/ageing/29.5.451

M. Roberts, J. Stokes, and M. King, Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes, British Journal of Clinical Pharmacology, vol.42, issue.3, pp.257-65, 2001.
DOI : 10.1046/j.1365-2125.2001.00347.x

A. Zermansky, D. Alldred, D. Petty, D. Raynor, N. Freemantle et al., Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial, Age and Ageing, vol.35, issue.6, pp.586-91, 2006.
DOI : 10.1093/ageing/afl075

C. Langebrake and H. Hilgarth, Clinical pharmacists??? interventions in a German University Hospital, Pharmacy World & Science, vol.30, issue.2, pp.194-203, 2010.
DOI : 10.1007/s11096-010-9367-z

M. Brulhart and J. Wermeille, Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes, International Journal of Clinical Pharmacy, vol.51, issue.1, pp.549-57, 2011.
DOI : 10.1007/s11096-011-9506-1

D. Gnjidic, L. Couteur, D. Kouladjian, L. Hilmer, and S. , Deprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes, Clinics in Geriatric Medicine, vol.28, issue.2, pp.237-53
DOI : 10.1016/j.cger.2012.01.006

S. Iyer, V. Naganathan, A. Mclachlan, L. Couteur, and D. , Medication Withdrawal Trials in People Aged 65 Years and Older, Drugs & Aging, vol.166, issue.12, pp.1021-1052, 2008.
DOI : 10.2165/0002512-200825120-00004

P. Haastrup, M. Paulsen, L. Begtrup, J. Hansen, and D. Jarbøl, Strategies for discontinuation of proton pump inhibitors: a systematic review, Family Practice, vol.31, issue.6, 2014.
DOI : 10.1093/fampra/cmu050

C. Reimer, B. Søndergaard, L. Hilsted, and P. Bytzer, Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy, Gastroenterology, vol.137, issue.1, pp.80-87, 2009.
DOI : 10.1053/j.gastro.2009.03.058

A. Lødrup, C. Reimer, and P. Bytzer, Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment, Scandinavian Journal of Gastroenterology, vol.24, issue.5, 2013.
DOI : 10.1080/00365520510011579

E. Reeve, J. To, I. Hendrix, S. Shakib, M. Roberts et al., Patient Barriers to and Enablers of Deprescribing: a Systematic Review, Drugs & Aging, vol.13, issue.10, pp.793-807, 2013.
DOI : 10.1007/s40266-013-0106-8

S. Anthierens, A. Tansens, M. Petrovic, and T. Christiaens, Qualitative insights into general practitioners views on polypharmacy, BMC Family Practice, vol.5, issue.3, p.65, 2010.
DOI : 10.1016/j.amjopharm.2007.03.004

B. Farrell, C. Tsang, L. Raman-wilms, H. Irving, J. Conklin et al., What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process, PLOS ONE, vol.1, issue.Suppl 2, p.122246, 2015.
DOI : 10.1371/journal.pone.0122246.s003

H. G. Van-spall, A. Toren, A. Kiss, and R. A. Fowler, Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals, JAMA, vol.297, issue.11, pp.1233-1240, 2007.
DOI : 10.1001/jama.297.11.1233

M. Wehling, GUIDELINE-DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS, Journal of the American Geriatrics Society, vol.57, issue.2, 2011.
DOI : 10.1111/j.1532-5415.2011.03252.x

S. Jackson, P. Jansen, and A. Mangoni, Off-label prescribing in older patients. Drugs Aging, pp.427-461, 2012.

. Saint-etienne and . Fra, Les facteurs non médicaux de la décision médicale dans le cadre de la prescription des IPP, Recherche sur le système de santé : 2005-2007. Saint-Etienne: RN3S, pp.237-83, 2008.

A. Lanas and C. Gargallo, Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective, Journal of Gastroenterology, vol.11, issue.1, pp.626-663
DOI : 10.1007/s00535-015-1038-3

P. Malfertheiner, F. Chan, and K. Mccoll, Peptic ulcer disease, The Lancet, vol.374, issue.9699, pp.1449-61, 2009.
DOI : 10.1016/S0140-6736(09)60938-7

L. Mcquaid and . Laine, Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials, The American Journal of Medicine, vol.119, issue.8, pp.624-662, 2006.
DOI : 10.1016/j.amjmed.2005.10.039

F. Lanza, F. Chan, and E. Quigley, Guidelines for Prevention of NSAID-Related Ulcer Complications, The American Journal of Gastroenterology, vol.328, issue.3, pp.728-766, 2009.
DOI : 10.1038/ajg.2009.115

K. Lapane and C. Hughes, Which organizational characteristics are associated with increased management of depression using antidepressants in US nursing homes? Med Care, pp.992-1000, 2004.

P. Rochon, T. Stukel, S. Bronskill, T. Gomes, K. Sykora et al., Variation in Nursing Home Antipsychotic Prescribing Rates, Archives of Internal Medicine, vol.167, issue.7, pp.676-83, 2007.
DOI : 10.1001/archinte.167.7.676

C. Hughes and K. Lapane, Pharmacy interventions on prescribing in nursing homes: from evidence to practice. Ther Adv Drug Saf, pp.103-115, 2011.

A. Fleming, J. Browne, and S. Byrne, The Effect of Interventions to Reduce Potentially Inappropriate Antibiotic Prescribing in Long-Term Care Facilities: a Systematic Review of Randomised Controlled Trials, Drugs & Aging, vol.332, issue.7538, pp.401-409
DOI : 10.1007/s40266-013-0066-z

A. Régionale-de-santé-aquitaine, Outil Diagnostic de la prise en charge médicamenteuse en EHPAD. [internet]. [accès le 11, Disponible sur, 2015.

Â. Sexe-indice-de-masse-corporel-groupe, Ressource Prise en charge en secteur sécurisé Durée moyenne de présence Changement de médecin traitant à l'entrée FOGD dans l'année Recherche d'HP dans l'année Evènement(s) hémorragique(s) dans l'année Hospitalisation(s) dans l'année Prescription d'IPP : Indication Dosage Horaire de prise Molécule Durée du traitement Traitement antérieur à l'entrée en EHPAD Co-prescriptions : Anti agrégant plaquettaire Anticoagulant AINS Corticoïdes ABSTRACT Long term use of proton pump inhibitors in nursing home: documented indications and associated prescriptions for 134 residents